Menorrhagia in Women After the Administration of Novel Oral Anticoagulants, Like Rivaroxaban: A Case Report
International Journal of Medical Toxicology and Forensic Medicine,
Vol. 10 No. 3 (2020),
27 September 2020
Background: The Novel Oral Anticoagulants (NOACs), despite numerous benefits, such as the ease of use and less drug involvement, provide extensive adverse effects. One of the most significant, but rare side effects of them in women is severe and dangerous bleeding
Case presentation: In this study, we reported a case of severe vaginal bleeding (manometric hemorrhage) in a woman receiving rivaroxaban to prevent pulmonary thrombosis.
Conclusion: The oral anticoagulant rivaroxaban could present a rare adverse effect on women.
- Vascular thrombosis
How to Cite
- Abstract Viewed: 9 times
- pdf Downloaded: 1 times